EU Commission: Illumina/GRAIL prohibition antitrust case

Decision

Regulator

ECEuropean Commission

acted against

Against

IlluminaGRAIL

The Commission blocked Illumina's acquisition of cancer test developer GRAIL, finding it would stifle innovation in blood-based early cancer detection.

Related cases

AntitrustActiveUnverifiedfiled Oct 2026CMA: LidlPotential designation of Aldi and Lidl under the Groceries Market Investigation (Controlled Land) Order 2010UK CMAAntitrustActiveUnverifiedfiled Oct 2026FTC: PublicisFTC Order Preserves Competition in Digital Advertising Ecosystem as Part of Publicis’s Acquisition of LiveRampFTCAntitrustActiveUnverifiedfiled Oct 2026California AG: LyftAttorney General Bonta, City Attorneys of San Francisco, San Diego, and Los Angeles, Labor Commissioner, and Private Plaintiffs Reach Landmark $272.5 Million Settlement Securing Monetary Relief for Misclassified Lyft DriversCalifornia Attorney GeneralAntitrustActiveUnverifiedfiled Aug 2026FTC: ZillowFTC Secures Order Resolving Antitrust Concerns with Zillow-Redfin AgreementFTCAntitrustDecidedfiled Jul 2026EU Commission: Google DMA finesIn two non-compliance decisions, the Commission found Google favoured its own services in Search results and restricted app developers on Google Play from steering users to other purchase channels.EUR 890 millionEuropean CommissionAntitrustClosedfiled Jul 2026EU Commission: SAP ERP support commitmentsSAP committed to let customers split their SAP landscape among support providers and to terminate licences and support fees in specific scenarios.European CommissionAntitrustActiveUnverifiedfiled Jul 2026HHaugland sued v. Alphabet Inc.An antitrust suit.D. HawaiiAntitrustActivefiled Jun 2026EU Commission: AWS and Azure DMA cloud investigationThe Commission told Amazon and Microsoft it preliminarily considers AWS and Azure should be designated as gatekeeper cloud services despite not meeting the DMA's quantitative thresholds.European Commission